ETMR brain tumor trial for children
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial is for children with a rare brain tumor (ETMR) who have not had radiation. Depending on how much tumor is left after surgery and if it has spread, the study compares giving radiation early versus high-dose chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a specific type of brain tumor called ETMR (embryonal tumor with multilayered rosettes).
- You cannot have had radiation therapy for this tumor.
- Depending on your situation (surgery results, age, spread of disease), you'll be placed into one of several treatment groups.
- You need good blood counts, kidney, and liver function before starting.
- Women who can become pregnant and men must use birth control during and for 4 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two drugs (eflornithine and AMXT 1501) for children and young adults with certain types of cancer that have relapsed or not responded to standard treatment, or for a specific brain tumor (DIPG) at diagnosis. The goal is to see if this drug pair is safe and effective.
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
This registry research program collects information and tumor samples from people with a specific type of brain embryonal tumor (with multilayer rosettes). It may help researchers understand the tumor better and improve future treatments.
This trial tests a new immune therapy using your child's own specially trained white blood cells to fight brain tumors. The treatment is given directly into the fluid around the brain, and it is for children with specific types of brain cancer.
This study is an international registry (a way to collect medical information) for people with certain rare brain tumors, diagnosed since 2010. It helps researchers understand these tumors better, which can guide future treatments.
This trial tests a targeted drug (entrectinib) in very young children (under 3) with a newly diagnosed brain tumor that has a specific genetic change (NTRK or ROS1 fusion). The drug works by blocking signals that help the tumor grow, and is given as the first treatment, before any chemotherapy or radiation.
Hear when a new Embryonal Tumor With Multilayered Rosettes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.